Continuous Glucose Monitoring for the Routine Care of Type 2 Diabetes Mellitus

Overview

Journal Nat Rev Endocrinol

Specialty Endocrinology

Date 2024 Apr 8

PMID 38589493

Authors

Ramzi A Ajjan

Tadej Battelino

Xavier Cos

Stefano Del Prato

Jean-Christophe Philips

Laurent Meyer

Jochen Seufert

Samuel Seidu

Affiliations

Soon will be listed here.

Abstract

Although continuous glucose monitoring (CGM) devices are now considered the standard of care for people with type 1 diabetes mellitus, the uptake among people with type 2 diabetes mellitus (T2DM) has been slower and is focused on those receiving intensive insulin therapy. However, increasing evidence now supports the inclusion of CGM in the routine care of people with T2DM who are on basal insulin-only regimens or are managed with other medications. Expanding CGM to these groups could minimize hypoglycaemia while allowing efficient adaptation and escalation of therapies. Increasing evidence from randomized controlled trials and observational studies indicates that CGM is of clinical value in people with T2DM on non-intensive treatment regimens. If further studies confirm this finding, CGM could soon become a part of routine care for T2DM. In this Perspective we explore the potential benefits of widening the application of CGM in T2DM, along with the challenges that must be overcome for the evidence-based benefits of this technology to be delivered for all people with T2DM.

Citing Articles

"Now I can see it works!" Perspectives on Using a Nutrition-Focused Approach When Initiating Continuous Glucose Monitoring in People with Type 2 Diabetes: Qualitative Interview Study.

Willis H, Henderson M, Zibley L, JaKa M JMIR Diabetes. 2025; 10():e67636.

PMID: 39793006 PMC: 11759913. DOI: 10.2196/67636.

Intermittent Use of Flash Glucose Monitoring Improves Glycemic Control in Chinese Older Patients with Type 2 Diabetes Mellitus.

Hu Y, Yan R, Shen Y, Li H, Ma J, Su X Diabetes Metab Syndr Obes. 2025; 18():1-9.

PMID: 39781244 PMC: 11705963. DOI: 10.2147/DMSO.S498620.

Association between time in tight range and incident diabetic retinopathy in adults with type 2 diabetes.

Wang Y, Lu J, Yu J, Ni J, Wang M, Lu W Diabetes Obes Metab. 2024; 27(3):1415-1422.

PMID: 39696843 PMC: 11802404. DOI: 10.1111/dom.16143.

Prognostic value of glycaemic variability for mortality in critically ill atrial fibrillation patients and mortality prediction model using machine learning.

Chen Y, Yang Z, Liu Y, Gue Y, Zhong Z, Chen T Cardiovasc Diabetol. 2024; 23(1):426.

PMID: 39593120 PMC: 11590403. DOI: 10.1186/s12933-024-02521-7.

Initiating continuous glucose monitoring is associated with improvements in glycemic control and reduced health care resource utilization for people with diabetes in a large US-insured population: A real-world evidence study.

Norman G, Fernandes J, Nemlekar P, Andrade S, Lupton L, Berk A J Manag Care Spec Pharm. 2024; 31(1):15-24.

PMID: 39549039 PMC: 11697583. DOI: 10.18553/jmcp.2024.24255.

References

Davies M, Aroda V, Collins B, Gabbay R, Green J, Maruthur N . Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2022; 65(12):1925-1966. PMC: 9510507. DOI: 10.1007/s00125-022-05787-2. View

Powers M, Bardsley J, Cypress M, Funnell M, Harms D, Hess-Fischl A . Diabetes Self-management Education and Support in Adults With Type 2 Diabetes: A Consensus Report of the American Diabetes Association, the Association of Diabetes Care and Education Specialists, the Academy of Nutrition and Dietetics, the American.... J Acad Nutr Diet. 2021; 121(4):773-788.e9. DOI: 10.1016/j.jand.2020.04.020. View

Powers M . 2016 Health Care & Education Presidential Address: If DSME Were a Pill, Would You Prescribe It?. Diabetes Care. 2016; 39(12):2101-2107. DOI: 10.2337/dc16-2085. View

Chrvala C, Sherr D, Lipman R . Diabetes self-management education for adults with type 2 diabetes mellitus: A systematic review of the effect on glycemic control. Patient Educ Couns. 2015; 99(6):926-43. DOI: 10.1016/j.pec.2015.11.003. View

Fisher L, Hessler D, Glasgow R, Arean P, Masharani U, Naranjo D . REDEEM: a pragmatic trial to reduce diabetes distress. Diabetes Care. 2013; 36(9):2551-8. PMC: 3747867. DOI: 10.2337/dc12-2493. View

Chatterjee S, Davies M, Heller S, Speight J, Snoek F, Khunti K . Diabetes structured self-management education programmes: a narrative review and current innovations. Lancet Diabetes Endocrinol. 2017; 6(2):130-142. DOI: 10.1016/S2213-8587(17)30239-5. View

Stratton I, Adler A, Neil H, Matthews D, Manley S, Cull C . Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000; 321(7258):405-12. PMC: 27454. DOI: 10.1136/bmj.321.7258.405. View

Holman R, Paul S, Bethel M, Matthews D, Neil H . 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008; 359(15):1577-89. DOI: 10.1056/NEJMoa0806470. View

Lind M, Imberg H, Coleman R, Nerman O, Holman R . Historical HbA Values May Explain the Type 2 Diabetes Legacy Effect: UKPDS 88. Diabetes Care. 2021; . PMC: 8740943. DOI: 10.2337/dc20-2439. View

10.

Paul S, Klein K, Thorsted B, Wolden M, Khunti K . Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes. Cardiovasc Diabetol. 2015; 14:100. PMC: 4528846. DOI: 10.1186/s12933-015-0260-x. View

11.

Mateo J, Gil-Guillen V, Mateo E, Orozco D, Carbayo J, Merino J . Multifactorial approach and adherence to prescribed oral medications in patients with type 2 diabetes. Int J Clin Pract. 2006; 60(4):422-8. DOI: 10.1111/j.1368-5031.2006.00799.x. View

12.

Safford M, Shewchuk R, Qu H, Williams J, Estrada C, Ovalle F . Reasons for not intensifying medications: differentiating "clinical inertia" from appropriate care. J Gen Intern Med. 2007; 22(12):1648-55. PMC: 2219839. DOI: 10.1007/s11606-007-0433-8. View

13.

Khunti K, Nikolajsen A, Thorsted B, Andersen M, Davies M, Paul S . Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin. Diabetes Obes Metab. 2016; 18(4):401-9. PMC: 5067688. DOI: 10.1111/dom.12626. View

14.

Seidu S, Than T, Kar D, Lamba A, Brown P, Zafar A . Therapeutic inertia amongst general practitioners with interest in diabetes. Prim Care Diabetes. 2017; 12(1):87-91. DOI: 10.1016/j.pcd.2017.09.001. View

15.

Khunti K, Davies M . Clinical inertia-Time to reappraise the terminology?. Prim Care Diabetes. 2017; 11(2):105-106. DOI: 10.1016/j.pcd.2017.01.007. View

16.

Doyle-Delgado K, Chamberlain J, Shubrook J, Skolnik N, Trujillo J . Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline. Ann Intern Med. 2020; 173(10):813-821. DOI: 10.7326/M20-2470. View

17.

Khunti K, Gomes M, Pocock S, Shestakova M, Pintat S, Fenici P . Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review. Diabetes Obes Metab. 2017; 20(2):427-437. PMC: 5813232. DOI: 10.1111/dom.13088. View

18.

Kaewbut P, Kosachunhanun N, Phrommintikul A, Chinwong D, Hall J, Chinwong S . Time to Treatment Intensification to Reduce Diabetes-Related Complications: A Post Hoc Study. Healthcare (Basel). 2022; 10(9). PMC: 9498838. DOI: 10.3390/healthcare10091673. View

19.

Bain S, Bekker Hansen B, Hunt B, Chubb B, Valentine W . Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UK. J Med Econ. 2019; 23(1):98-105. DOI: 10.1080/13696998.2019.1645018. View

20.

Tsotra F, Kappel M, Peristeris P, Bader G, Levi E, Lister N . The societal impact of early intensified treatment in patients with type 2 diabetes mellitus. J Comp Eff Res. 2022; 11(16):1185-1199. DOI: 10.2217/cer-2022-0110. View